Epigenetic events associated with breast cancer and their prevention by dietary components targeting the epigenome

Chemical Research in Toxicology

Volumn 25, Issue 1, 2012, Pages 61-73

  Khan, Shabana I ^a,b   Aumsuwan, Pranapda ^a,b   Khan, Ikhlas A ^a,b,c   Walker, Larry A ^a,b   Dasmahapatra, Asok K ^a,b  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; DNA METHYLTRANSFERASE; EPIGALLOCATECHIN GALLATE; GENISTEIN; ISOTHIOCYANIC ACID DERIVATIVE; METHYL CPG BINDING PROTEIN; MICRORNA; POLYPHENOL; RESVERATROL; SULFORAPHANE;

BREAST CANCER; CANCER PREVENTION; DNA METHYLATION; EPIGENETICS; FOOD INTAKE; HISTONE MODIFICATION; HUMAN; NONHUMAN; REVIEW; SOYBEAN;

ANIMALS; ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; DIET; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DNA-BINDING PROTEINS; EPIGENOMICS; FEMALE; HISTONES; HUMANS; MICRORNAS;

CURCUMA LONGA; GLYCINE MAX; VITACEAE;

EID: 84855862393     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx200378c     Document Type: Review

References (179)

1. Ordway, J. M., Budiman, M. A., Korshunova, Y., Maloney, R. K., Bedell, J. A., Citek, J. A., Bacher, B., Peterson, S., Rohlfing, S., Rohlfing, T., Hall, J., Brown, R., Lakey, N., Doerge, R. W., Martienssen, R. A., Leon, J., McPherson, J. D., and Jeddeloh, J. A. (2007) Identification of novel high-frequency DNA methylation changes in breast cancer PLoS One 19, e1314
2. Feuer, E. J., Wun, L. M., Boring, C. C., Flanders, W. D., Timmel, M. J., and Tong, T. (1993) The lifetime risk of developing breast cancer J. Natl. Cancer Inst. 85, 892-897 (Pubitemid 23157129)
3. Lin, S.-X., Chen, J., Mazumdar, M., Poirier, D., Wang, C., Azzi, A., and Zhou, M.. (2010) Molecular therapy of breast cancer: progress and future directions Nat. Rev. Endocrinol. 6, 485-493
4. Cebrian, A., Pharoah, P. D., Ahmed, S., Ropero, S., Frage, M. F., Smith, P. L., Conroy, D., Luben, R., Perkins, B., Easton, D. F., Dunning, A. M., Esteller, M., and Ponder, B. A. J. (2006) Genitic variants in epigenetic genes and breast cancer risk Carcinogenesis 27, 1661-1669 (Pubitemid 44303919)
5. Veeck, J. and Esteller, M. (2010) Breast cancer epigenetics: from DNA methylation to microRNAs J. Mammary Gland Biol. Neoplasia 15, 5-17
6. Topper, Y. J. and Freeman, C. S. (1980) Multiple hormone interactions in the developmental biology of the mammary gland Physiol. Rev. 60, 1049-1106
7. Devinoy, E. and Rijnkels, M. (2010) Epigenetics in mammary gland biology and cancer J. Mammary Gland Biol. Neoplasia 15, 1-4
8. Kress, C., Ballester, M., Devinoy, E., and Rijnkels, M. (2010) Epigenetic modifications in 3D: nuclear organization of the differentiating mammary epithelial cell J. Mammary Gland Biol. Neoplasia 15, 73-83
9. Rijnkels, M., Kabotyanski, E., Montazer-Torbati, M. B., Beauvais, C. H., Vassetzky, Y, Rosen, J. M., and Devinoy, E. (2010) The epigenetic landscape of mammary gland development and functional differentiation J. Mammary Gland Biol. Neoplasia 15, 85-100
10. Mettlin, C. (1999) Global breast cancer mortality statistics CA Cancer J. Clin. 49, 138-144 (Pubitemid 29353927)
11. Agrawal, A., Yang, J., Murphy, R. F., and Agrawal, D. K. (2006) Regulation of the p14ARF- Mdm2-p53 pathway: an overview in breast cancer Exp. Mol. Pathol. 81, 155-122
12. Dworkin, A. M., Haung, T.H-M., and Toland, A. E. (2009) Epigenetic alterations in the breast: implications for breast cancer detection, prognosis and treatment Semin. Cancer Biol. 19, 165-171
13. Widschwendter, M. and Jones, P. A. (2002) DNA methylation and breast carcinogenesis Oncogene 21, 5462-5482 (Pubitemid 34983482)
14. Polyak, K. (2007) Breast cancer: origins and evolution J. Clin. Invest. 117, 3155-3163 (Pubitemid 350096968)
15. Lo, P. K. and Sukumar, S. (2008) Epigenomics and breast cancer Pharmacogenomics 9, 1879-1902
16. Nystrom, L., Andersson, I., Bjurstam, N., Nordenskjold, B., and Rutgvist, L. E. (2002) Long-term effects of mammography screening: updated overview of the swedish randomised trials Lancet 359, 909-919 (Pubitemid 34246378)
17. Miller, J. W., King, J. B., Ryerson, A. B., Eheman, C. R., and White, M. C. (2009) mammography use from 2000 to 2006: state-level trends with corresponding breast cancer incidence rates Am. J. Roentgenol. 192, 352-360
18. Radpour, R., Barekati, Z., Kohler, C., Holzgreve, W., and Zhong, X. Y. (2009a) New trends in molecular biomarker discovery for breast cancer Genet. Test Mol. Biomarkers 13, 565-571
19. Levenson, V. V. (2007) Biomarkers for early detection of breast cancer: what, when, and where? Biochim. Biophys. Acta 1170, 847-856 (Pubitemid 46617032)
20. Lehmann, U., Langer, F., Feist, H., Glockner, S., Hasemeier, B., and Kreipe, H. (2002) Quantitative assessment of promoter hypermethylation during breast cancer development Am. J. Pathol. 160, 605-612 (Pubitemid 34160338)
21. Subramaniam, M. M., Chan, J. Y., Soong, R., Ito, K., Ito, Y., Yeoh, K. G., Salto-Tellez, M., and Putti, T. C. (2009) RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression Breast Cancer Res. Treat. 113, 113-121
22. Dejeux, E., Ronneberg, J. A., Solvang, H., Bukholm, I, Geisler, S., Aas, T., Gut, L. G., Borresen-Dale, A-L, Lonning, P. E., Kristensen, V. L., and Tost, J. (2010) DNA methylation profiling in doxorubicin treated primary locally advanced breast cancer tumours identifies novel genes associated with survival and treatment response Mol. Cancer 9, 68
23. Yamamoto, N., Nakayama, T., Kajita, M., Miyake, T., Iwamoto, T., Kim, S. J., Sakai, A., Ishihara, H., Tamaki, Y., and Noguchi, S. (2011) Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay Breast Cancer Res. Treat. 10.1007/s10549-011-1575-2
24. Miyamoto, K. and Ushijima, T. (2005) Diagnostic and therapeutic applications of epigenetics Jap. J. Clin. Oncol. 35, 293-301 (Pubitemid 41444276)
25. Pfeifer, G. P. and Dammann, R. (2005) Methylation of the tumor suppressor gene RASSF1A in human tumors Biochemistry 70, 576-583 (Pubitemid 40920802)
26. Fackler, M. J., Malone, K., Zhang, Z., Schilling, E., Garrett-Mayer, E., Swift-Scanlan, T., lange, J., Nayar, R., Davidson, N. E., Khan, S. A., and Sukumar, S. (2006) Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid Clin. Cancer Res. 12, 3306-3310
27. Parrella, P. (2010) Epigenetic signatures in breast cancer: clinical perspective Breast Care 5, 66-73
28. Li, Y., Liu, L., Andrews, L. G., and Tollefbol, T. O. (2009) Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms Int. J. Cancer 125, 286-296
29. Khan, N., Afaq, F., and Mukhtar, H. (2008) Cancer chemoprevention through dietary antioxidants: progress and promise Antioxid. Redox Signaling 10, 475-510
30. Mense, S. M., Hei, T. K., Ganju, R. K., and Bhat, H. K. (2008) Phytoestrogens and breast cancer prevention: possible mechanisms of action Environ. Health Perspect. 116, 426-433 (Pubitemid 351864298)
31. Messina, M., McCaskill-Stevens, W., and Lampe, J. W. (2006) Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings J. Natl. Cancer Inst. 98, 1275-1284 (Pubitemid 44530723)
32. Ursin, G., Bernstein, L., and Pike, M. C. (1994) Breast cancer Cancer Sur. 19-20, 241-264 (Pubitemid 24289388)
33. Steiner, C., Arnould, S., Scalbert, A., and Manach, C. (2008) Isoflavones and the prevention of breast and prostate cancer: new perspectives opened by nutrigenomics Br. J. Nutr. 99 (Suppl 1) ES78-ES108
34. Hsieh, C. Y., Santell, R. C., Haslam, S. Z., and Helferich, W. G. (1998) Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo Cancer Res. 58, 3833-3838 (Pubitemid 28405638)
35. Allred, C. D., Ju, Y. H., Allred, K. F., Chang, J., and Helferich, W. G. (2001) Dietary genistein stimulates growth of estrogen-dependent breast cancer tumors similar to that observed with genistein Carcinogenesis 22, 1667-1673 (Pubitemid 32952145)
36. de Lemos, M. L. (2001) Effects of soy phytoestrogens genistein and daidzein on breast cancer growth Ann. Pharmacother. 35, 118-1121
37. Shu, X. O., Jin, F., Dai, Q., Wen, W., Potter, J. D., Kushi, L. H., Ruan, Z., gao, Y. T., and Zheng, W. (2001) Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women Cancer Epidemiol. Biomarkers Prev. 10, 483-488 (Pubitemid 32701634)
38. Wu, A. H., Wan, P., Hankin, J., Tseng, C. C., Yu, M. C., and Pike, M. C. (2002) Adolescent and adult soy intake and risk of breast cancer in Asian-Americans Carcinogenesis 23, 1491-1496 (Pubitemid 35012429)
39. Lamartiniere, C. A., Cotroneo, M. S., Fritz, W. A., Wang, J., Mentor-Marcel, R., and Elgavish, A. (2002) Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate J. Nutr. 132, 552S-558S (Pubitemid 34208769)
40. Jawaid, K., Crane, S. R., Nowers, J. L., lacey, M., and Whitehead, S. A. (2010) Long-term genistein of MCF-7 cells decreases acetylated histone 3 expression and alters growth responses to mitogens and histone deacetylases inhibitors J. Steroid Biochem. Mol. Biol. 120, 164-171
41. Chekhun, V. F., Lukyanova, N. Y., Kovalchuk, O., Tryndyak, V. P., and Pogribny, I. P. (2007) Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper- and hypomethylated targets Mol. Cancer Ther. 6, 1089-1098 (Pubitemid 46554580)
42. Jovanovic, J., Ronneberg, J. A., Tost, J., and Kristen, V. (2010) The epigenetics of breast cancer Mol. Oncol. 4, 242-254
43. Suzuki, T. and Miyata, N. (2006) Epigenetic control using natural products and synthetic molecules Curr. Med. Chem. 13, 935-958
44. Hauser, A.-T. and Jung, M. (2008) Targeting epigentic mechanisms: potential of natural products in cancer chemoprevention Planta Med. 74, 1593-1601
45. Li, Y. and Tollefsbol, T. O. (2010) Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components Curr. Med. Chem. 17, 2141-2151
46. Meeran, S. M., Ahmed, A., and Tollefsbol, T. O. (2010) Epigenetic targets of bioactive dietary components for cancer prevention and therapy Clin. Epigenetics 1, 101-116
47. Jones, P. A. and Laird, P. W. (1999) Cancer epigenetics comes of age Nat. Genet. 2, 163-167 (Pubitemid 29070360)
48. Wolffe, A. P. and Matzke, M. A. (1999) Epigenetics: regulation through repression Science 286, 481-486
49. Portela, A. and Esteller, M. (2010) Epigenetic modifications and human disease Nat. Biotechnol. 28, 1057-1068
50. Momparler, R. L. (2003) Cancer epigenetics Oncogene 22, 6479-6483 (Pubitemid 37372327)
51. Yoo, C. B. and Jones, P. A. (2006) Epigenetic therapy of cancer: past, present and future Nat. Rev. Drug Discovery 5, 37-50
52. Jaenisch, R. and Bird, A. (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals Nat. Genet. 33 (Suppl) 245-254 (Pubitemid 36278835)
53. Kristensen, L. S., Nielsen, H. M., and Hansen, L. L. (2009) Epigenetics and cancer treatment Eur. J. Pharmacol. 625, 131-142
54. Lustberg, M. B. and Ramaswamy, B. (2009) Epigenetic targeting in breast cancer: therapeutic impact and future direction Drug News Perspect. 22, 369-381
55. Pathiraja, T. N., Stearns, V, and Oesterreich, S. (2010) Epigenetic regulation in estrogen receptor positive breast cancer-role in treatment response J. Mammary Gland Biol. Neoplasia 15, 35-47
56. Fan, J., Yin, W. J., Lu, J. S., Wang, L., Wu, J., Wu, F. Y., Di, G. H., Shen, Z. Z., and Shao, Z. M. (2008) ER alpha negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor J. Cancer Res. Clin. Oncol. 134, 883-890
57. Bai, Z. and Gust, R. (2009) Breast cancer, estrogen receptor and ligands Arch. Pharm. (Weinheim, Ger.) 342, 133-149
58. Zwart, W., Theodorou, V., and Carroll, J. S. (2011) Estrogen receptor-positive breast cancer: a multidisciplinary challenge Wiley Interdiscip. Rev. Syst. Biol. Med. 3, 216-230
59. Jonat, W., Pritchard, K. I., Sainsbury, R., and Klijn, J. G. (2006) Trends in endocrine therapy and chemotherapy for early breast cancer: a focus on the premenopausal patient J. Cancer Res. Clin. Oncol. 132, 275-286
60. Myutan, K., Mahamed, S., and Kefah, M. (2009) Estrogen-synthesizing enzymes and breast cancer Anticancer Res. 29, 1095-1109
61. Khan, S., Zhao, J., Khan, I. A., Walker, L. A., and Dasmahapatra, A. K. (2011) Potential utility of natural products as regulators of breast cancer-associated aromatase promoters Reprod. Biol. Endocrinol. 9, 91
62. Giacinti, L., Claudio, P. P., Lopez, M., and Giordano, A. (2006) Epigenetic information and estrogen receptor alpha expression in breast cancer Oncologist 11, 1-8 (Pubitemid 43152681)
63. Zhou, Q., Atadja, P., and Davidson, N. E. (2007) Histone deacetylases inhibitor LBH589 reactivates silenced estrogen receptor alpha (ER) gene expression without loss of DNA methylation Cancer Biol. Ther. 6, 64-69 (Pubitemid 46294178)
64. Yan, P. S., Chen, C. M., Shi, H., Rahmatpanah, F., Wei, S. H., Caldwell, C. W., and Huang, T. H. (2001) Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays Cancer Res. 61, 8375-8380 (Pubitemid 33131108)
65. Guler, G., Iliopoulos, D., Guler, N., Himmetoglu, C., Hayran, M., and Huebner, K. (2007) Wwox and Ap2γ expression levels predict tamoxifen response Clin. Cancer Res. 13, 6115-6121 (Pubitemid 350075070)
66. Ushijima, T. (2007) Epigenetic field for cancerrization J. Biochem. Mol. Biol. 40, 142-150
67. Sun, Z., Asmann, Y. W., Kalari, K. R., Bot, B., Eckel-Passow, J. E., Baker, T. R., Carr, J. M., Khrebtukova, I., Luo, S., Zhang, L., Schroth, G. P., Perez, E. A., and Thompson, E. A. (2011) Integrated analysis of gene expression, CpG island methylation, and gene copy number in breast cancer cells by deep sequencing PLoS One 6, e17490
68. Radpour, R, Kohler, C., Haghighi, M. M., Fan, A. X., Holzgreve, W., and Zhong, X. Y. (2009b) Methylation profiles of 22 candidate genes in breast cancer using high-throughput MALDI-TOF mass array Oncogene 28, 2969-2878
69. Muller, C. I., Ruter, B., Koeffler, H. P., and Lubbert, M. (2006) DNA hypermethylation of myeloid cells, a novel therapeutic target in MDS and AML Curr. Pharm. Biotechnol. 7, 315-321 (Pubitemid 44524413)
70. Oki, Y. and Issa, J. P. (2007) Treatment options in advanced myelodysplastic syndrome, with emphasis on epigenetic therapy Int. J. Hematol. 86, 306-314
71. Mai, A. and Altucci, L. (2009) Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead Int. J. Biochem. Cell Biol. 41, 199-213
72. Manson, M. M., Farmer, P. B., Gescher, A., and Steward, W. P. (2005) Innovative agents in cancer prevention Recent Results Cancer Res. 166, 257-275
73. Stoner, G. D. and Mukhtar, H. (1995) Polyphenols as cancer chemopreventive agents J. Cell. Biochem. Suppl. 22, 169-180
74. Seo, H. S., Ju, J. H., Jang, K., and Shin, I. (2011) Induction of apoptotic cell death by phytoestrogens by up-regulating the levels of phosphor-p53 and p21 in normal and malignant estrogen receptor α-negative breast cells Nutr. Res. (N.Y.) 31, 139-146
75. Aggarwal, B. B., Kumar, A., and Bharti, A. C. (2003) Anticancer potential of curcumin: preclinical and clinical studies Anticancer Res. 23, 363-398 (Pubitemid 36361976)
76. Shishodia, S, Shing, T., and Chaturvedi, M. M. (2007) Modulation of transcription factors by curcumin Adv. Exp. Med. Biol. 595, 127-148
77. Okano, M., Xie, S., and Li, E. (1998) Dnmt2 is not required for de novo and maintenance methylation of viral DNA in embryonic stem cells Nucleic Acids Res. 26, 2536-2540 (Pubitemid 28297362)
78. Rai, K., Chidester, S., Zavala, C. V., Manos, E. J., James, S. R., Karpf, A., RD., A., and Cairns, B. R. (2007) DNMT2 functions in the cytoplasm to promote liver, brain, and retina development in zebrafish Genes Dev. 21, 261-266
79. Goll, M. G., Kirpekar, F., Maggert, K. A., Yoder, J. A., Hsieh, C. L., Zhang, X., Golic, K. G., Jacobsen, S. E., and Bestor, T. H. (2006) Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2 Science 311, 395-398 (Pubitemid 43132667)
80. Girault, I., Tozlu, S., Lidereau, R., and Bieche, I. (2003) Expression analysis of DNMT methyltransferases 1, 3A, and 3B in sporadic breast carcinomas Clin. Cancer Res. 9, 4415-4422 (Pubitemid 37248399)
81. Roll, J. D., Rivenbark, A. G., Jones, W. D., and Coleman, W. B. (2008) DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines Mol. Cancer 7, 15
82. Medina-Franco, J. L. and Caulfield, T. (2011) Advances in the computational development of DNA methyltransferase inhibitors Drug Discovery Today 16, 418-425
83. Wu, J. C. and Santi, D. V. (1987) Kinetic and catalytic mechanism of Hhal methyltransferase J. Biol. Chem. 262, 4778-4786 (Pubitemid 17102852)
84. Chen, L, MacMillan, A. M., Chang, W., Ezaz-Nikpay, K., Lane, W. S., and Verdine, G. L. (1991) Direct identification of the active-site nucleophile in a DNA (cytosine-5)-methyltransferase Biochemistry 30, 11018-11025
85. O'Gara, M., Klimasauskas, S., Roberts, R. J., and Cheng, X. (1996) Enzymatic C5-cytosine methylation of DNA: mechanistic implications of new crystal structures for Hhal methyltransferase-DNA-AdoHcy complexes J. Mol. Biol. 261, 634-645 (Pubitemid 26300798)
86. Mistry, A. R., Pedersen, E. W., Solomon, E., and Grimwade, D. (2003) The molecular pathogenesis of acute promyelocytic leukaemia: implications for the clinical management of the disease Blood Rev. 17, 71-97 (Pubitemid 36372973)
87. Rountree, M. R., Bachman, K. E., and baylin, S. B. (2000) DNMT1 binds HDAC2 and a new co- repressor, DMAP1, to form a complex at replication foci Nat. Genet. 25, 269-277 (Pubitemid 30437311)
88. Campanero, M. R., Armstrong, M. I., and Flemington, E. K. (2000) CpG methylation as a mechanism for the regulation of E2F activity Proc. Natl. Acad. Sci. U.S.A. 97, 6481-6486 (Pubitemid 30412739)
89. Perini, G., Diolaiti, D., Porro, A., and Della Valle, G. (2005) In vivo transcriptional regulation of N-Myc target genes is controlled by E-box methylation Proc. Natl. Acad. Sci. U.S.A. 102, 12117-12122 (Pubitemid 41291138)
90. Pavlopoulou, A. and Kossida, S. (2010) Cytosine methyltransferases as tumor markers Cur. Gen. 11, 568-577
91. Kim, K.-B. (2010) CpG Islands detector: a window-based CpG island search tool Genomics Inf. 8, 58-61
92. Stearns, V., Zhou, Q., and Davidson, N. E. (2007) Epigenetic regulation as a new target for breast cancer therapy Cancer Invest. 25, 659-665 (Pubitemid 350223167)
93. Silva, J., Silva, J. M., Dominguez, G., garcia, J. M., cantos, B., Rodriguez, R., larrondo, F. J., Provencio, M., Espana, P., and Bonilla, F. (2003) Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms J. Pathol. 199, 289-297 (Pubitemid 36266851)
94. Jin, Z., Tamura, G., Tsuchiya, T., Sakata, K., Kashiwaba, M., Osakabe, M., and Motoyama, T. (2001) Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers Br. J. Cancer 85, 69-73 (Pubitemid 32695718)
95. Birgisdottir, V., Stefansson, O. A., Bodvarsdottir, S. K., Hilmarsdottir, H., Jonasson, J. G., and Eyfjord, J. E. (2006) Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer Breast Cancer Res. 8, R38
96. Gupta, A., Godwin, A. K., Vanderveer, L., Lu, A., and Liu, J. (2003) Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma Cancer Res. 63, 664-673 (Pubitemid 36158146)
97. Lee, W. J. and Zhu, B. T. (2006) Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols Carcinogenesis 27, 269-277 (Pubitemid 43159879)
98. Paluszczak, J., Krajka-Kuzniak, V., and Baer-Dubowska, W. (2010) The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells Toxicol. Lett. 192, 119-125
99. Lee, W. J., Shim, J. Y., and Zhu, B. T. (2005) Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids Mol. Pharmacol. 68, 1018-1030 (Pubitemid 41345793)
100. Meeran, S. M., Patel, S. N., Chan, T. H., and Tollefsbol, T. O. (2011) A novel prodrug of epigallocatechin-3-gallate: differential epigenetic hTERT repression in human breast cancer cells. Cancer Prev. Res., DOI, 10.1158/1940-6207.CAPR-11-0009.
101. King-Batoon, A., Leszczynska, J. M., and Klein, C. B. (2008) Modulation of gene methylation by genistein or lycopene in breast cancer cells Environ. Mol. Mutagen. 49, 36-45 (Pubitemid 351293011)
102. Qin, W., Zhu, W., Shi, H., Hewett, J. E., Ruhlen, R. L., MacDonald, R. S., Rottinghaus, G. E., Chen, Y. C., and Sauter, E. R. (2009) Soy isoflavones have an antiestrogenic effect and alter mammary promoter hypermethylation in healthy premenopausal women Nutr. Cancer 61, 238-244
103. Stefanska, B., Rudnicka, K., Bednarek, A., and Fabianowska-Majewska, K. (2010) Hypomethylation and induction of retinoic acid receptor beta 2 by concurrent action of adenosine analogues and natural compounds in breast cancer cells Eu. J. Pharmacol. 638, 47-53
104. Papoutsis, A. J., lamore, S. D., Wondrak, G. T., Selmin, O. I., and Romagnolo, D. F. (2010) Resveratrol prevents epigenetic silencing of BRCA-1 by the aromatic hydrocarbon receptor in human breast cancer cells J. Nutr. 140, 1607-1614
105. Schaefer, M., hagemann, S., hanna, K., and Lyko, F. (2009) Azacytidine inhibits RNA methylation at DNMT2 target sites in human cancer cell lines Cancer Res. 69, 8127-8132
106. Thomas, T. I. and Messner, R. P. (1986) Effects of lupus-inducing drugs on the B to Z transition of synthetic DNA Arthritis Rheum. 29, 638-645 (Pubitemid 16056832)
107. Zacharias, W. and Koopman, W. J. (1990) Lupus-inducing drugs alter the structure of supercoiled circular DNA domains Arthritis Rheum. 33, 366-374 (Pubitemid 20109188)
108. Fang, M. Z., Wang, Y., Ai, N., Hou, Z., Sun, Y., Lu, H., Welsh, W., and yang, C. S. (2003) Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in can cer cell lines Cancer Res. 63, 7563-7570 (Pubitemid 37466673)
109. Fang, M. J., Chen, D., Sun, Y., Jin, Z., Christman, J. K., and yang, C. S. (2005) Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and othr isoflavones from soy Clin. Cancer Res. 11, 7033-7041 (Pubitemid 41428763)
110. Liu, Z., Xie, Z., Jones, W., Pavlovicz, R. E., Liu, S., Yu, J., Li, P. K., Lin, J., Fuchs, J. R., Marcucci, G., Li, C., and Chan, K. K. (2009) Curcumin is a potent DNA hypomethylation agent Bioorg. Med. Chem. Lett. 19, 706-709
111. Fu, S. and Kurzrock, R. (2010) Development of curcumin as an epigenetic agent Cancer 116, 4670-4676
112. Fang, M., Chen, D., and Yang, C. S. (2007) Dietary polyphenols may affect DNA methylation J. Nutr. 137, 223S-228S (Pubitemid 46052885)
113. Jones, P. A. (2002) DNA methylation and cancer Oncogene 21, 5358-5360 (Pubitemid 34983472)
114. Kouzarides, T. (2007) Chromatin modifications and their function Cell 128, 693-705 (Pubitemid 46273577)
115. Vaissiere, T., Sawan, C., and Herceg, Z. (2008) Epigenetic interplay between histone modifications and DNA methylation in gene silencing Mutat. Res. 659, 40-48
116. Dhalluin, C., Carlson, J. E., Zeng, L., He, C., Aggarwal, A. K., and Zhou, M. M. (1999) Structure and ligand of a histone acetyltransferase bromodomain Nature 399, 491-496 (Pubitemid 29258857)
117. Luger, K., Mader, A. W., Richmond, R. K., Sergeant, D. F., and Richmond, T. J. (1997) Crystal structure of the nucleosome core particle at 2.8 A resolution Nature 398, 251-260 (Pubitemid 27406632)
118. Ito, K. and Adcock, I. M. (2002) Histone acetylation and histone deacetylation Mol. Biotechnol. 20, 99-106 (Pubitemid 34113578)
119. Strahl, B. D. and Allis, C. D. (2000) The language of covalent histone modifications Nature 403, 41-45 (Pubitemid 30038513)
120. Davis, C. D. and Ross, S. R. (2007) Dietary component impact histone modifications and cancer risk Nutr. Rev. 65, 88-94 (Pubitemid 351804383)
121. Minard, M. E., Jain, A. K., and Barton, M. C. (2009) Analysis of epigenetic alterations to chromatin during development Genesis 47, 559-572
122. Schubeler, D., MacAlpine, D. M., Scalzo, D., Wirbelauer, C., Kooperberg, C., van Leeuwen, F., Gottschling, D. E., O'Neill, L. P., Turner, B. M., Derlow, J., Bell, S. P., and Groudine, M. (2004) The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote Genes Dev. 18, 1263-1271 (Pubitemid 38720594)
123. Shilatifard, A. (2006) Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression Annu. Rev. Biochem. 75, 243-269 (Pubitemid 44118033)
124. Bronner, C., Fuhrmann, G., Chedin, F. L., Macaluso, M., and Dhe-Paganon, S. (2010) UHRF1 links the histone code and DNA methylation to ensure faithful epigenetic memory inheritance Genet. Epigenet. 2009, 29-36
125. Peterson, C. L. and Laniel, M. A. (2004) Histones and histone modifications Curr. Biol. 14, R546-551
126. Sims, R. J., III and Reinberg, D. (2006) Histone H3 Lys 4 methylation: caught in a bind? Genes Dev. 20, 2779-2786 (Pubitemid 44771740)
127. Travers, A. A. and Thompson, J. M. (2004) An introduction to the mechanics of DNA Philos. Trans. R. Soc., A 362, 1265-1279 (Pubitemid 38846191)
128. Martinez-Balbas, M. A., Bauer, U. M., Nielsen, S. J., Brehm, A., and Kouzarides, T. (2000) Regulation of E2F1 activity by acetylation EMBO J. 19, 662-671 (Pubitemid 30093739)
129. Roth, S. Y., Denu, J. M., and Allis, C. D. (2001) Histone acetyltransferases Annu. Rev. Biochem. 70, 81-120 (Pubitemid 32662206)
130. Deckert, J. and Struhl, K. (2001) Histone acetylation at promoters is differentially affected by specific activators and repressors Mol. Cell. Biol. 21, 2726-2735 (Pubitemid 32244917)
131. Gray, S. G. and Ekstrom, T. J. (2001) The human histone deacetylase family Exp. Cell. Res. 262, 75-83 (Pubitemid 32980246)
132. McLaughlin, F. and La Thangue, N. B. (2004) Histone deacetylases inhibitors open new doors in cancer therapy Biochem. Pharmacol. 68, 1139-1144 (Pubitemid 39094279)
133. Robertson, K. D., Ait-Si-Ali, S., Yokochi, T., Wade, P. A., Jones, P. L., and Wolffe, A. P. (2000) DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters Nat. Genet. 25, 338-342 (Pubitemid 30437325)
134. Gregoretti, I. V., Lee, Y. M., and Goodson, H. V. (2004) Molecular evolution of the histone deacetylases family: functional implications of phylogenetic analysis J. Mol. Biol. 338, 17-31 (Pubitemid 38429783)
135. Yamane, K., Tateishi, K., Klose, R. J., Fang, J., Fabrizio, L. A., Erdjument-Bromage, H., Taylor-Papadimitriou, Tempst, P., and Zhang, Y. (2007) PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation Mol. Cell 25, 801-812 (Pubitemid 46436533)
136. Banister, A. J. and Kouzarides, T. (2005) Reversing histone methylation Nature 436, 1103-1106 (Pubitemid 41232281)
137. Dalvai, M. and Bystricky, K. (2010) The role of histone modifications and variants in regulating gene expression in breast cancer J. Mammary Gland Biol. Neoplasia 15, 19-33
138. Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J. R., Cole, P. A., Casero, R. A., and Shi, Y. (2004) Histone demethylation mediated by the nuclear amine oxidase homolog LSD1 Cell 119, 941-953 (Pubitemid 40037608)
139. Tsukada, Y., fang, J., Erdjument-Bromage, H., Warren, M. E., Borchers, C. H., Tempst, P., and Zhang, Y. (2006) Histone demethylation by a family of JmjC domain-containing proteins Nature 439, 811-816 (Pubitemid 43255695)
140. Sung, B., Pandey, M. K., Ahn, K. S., Yi, T., Chaturvedi, M. M., Liu, M., and Aggarwal., B. B. (2008) Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappaB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-kappaB alpha kinase, leading to potentiation of apoptosis Blood 111, 4880-4891
141. Iyer, N. G., Ozdag, H., and Caldas, C. (2004) p300/CBP and cancer Oncogene 23, 4225-4231 (Pubitemid 38758588)
142. Eliseeva, E. D., Valkov, V., Jung, M., and Jung, M. O. (2007) Characterization of novel inhibitors of histone acetyl transferases Mol. Cancer Ther. 6, 2391-2398 (Pubitemid 47480404)
143. Balasubramanyam, K., Swaminathan, V., Ranganathan, A, and Kundu, T. K. (2003) Small molecule modulators of histone acetyltransferase p300 J. Biol. Chem. 23, 19134-19140 (Pubitemid 36799302)
144. Balasubramanyam, K., Varier, R. A., Altaf, M., Swaminathan, V., Siddappa, N. B., Ranga, U., and Kundu, T. K. (2004) Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription J. Biol. Chem. 279, 51163-51171 (Pubitemid 40017859)
145. Varier, R. A., Swaminathan, V., Balasubramanyam, K., and Kundu, T. K. (2004) Implications of small molecule activators and inhibitors of histone acetyltransferases in chromatin therapy Biochem. Pharmacol. 68, 1215-1220 (Pubitemid 39094287)
146. Choi, K. C., Jung, M. G., Lee, Y. H., Yoon, J. C., Kwon, S. H., Kang, H. B., Kim, M. J., Cha, J. H., Kim, Y. J., Jun, W. J., Lee, J. M., and Yoon, H. G. (2009) Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation Cancer Res. 69, 583-592
147. Lea, M. A., Rasheed, M., Randolph, V. M., Khan, F., Shareef, A., and desBordes, C. (2002) Induction of histone acetylation and inhibition of growth of mouse erythroleukemia cells by S-allymercaptocysteine Nutr. Cancer 43, 90-102 (Pubitemid 35387261)
148. Marks, P. A. (2007) Discovery and development of SAHA as an anticancer agent Oncogene 26, 1351-1356 (Pubitemid 46328465)
149. Thomas, S. and Munster, P. N. (2009) Histone deacetylases inhibitor induced modulation of anti-estrogen therapy Cancer Lett. 280, 184-191
150. Berletch, J. B., Liu, C., Love, W. K., Andrews, L. G., Katiyar, S. K., and Tollefsbol, T. O. (2008) Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG J. Cell Biochem. 103, 509-519 (Pubitemid 351171921)
151. Li, Y., Yuan, Y. Y., Meeran, S. M., and Tollefsbol, T. O. (2010) Synergistic epigenetic reactivation of estrogen receptor-α (ERα) by combined green tea polyphenol and histone deacetylases inhibitor in ERα-negative breast cancer cells Mol. Cancer 9, 274
152. Nian, H., Delage, B., Ho, E., and Dashwood, R. H. (2009) Modulation of histone deacetylase activity by dietary isothiocyanates and allyl sulfides: studies with sulforaphane and garlic organosulfur compounds Environ. Mol. Mutagen. 50, 213-221
153. Shapiro, T. A., Fahey, J. W., Dinkova-Kostova, A. T., Holtzclaw, W. D., Stephenson, K. K., Wade, K. L., Ye, L., and Talalay, P. (2006) safety, tolerance, and metabolism of broccoli sprout glucosinolates and isothiocyanates: a clinical phase I study Nutr. Cancer 55, 53-62 (Pubitemid 44477045)
154. Pledgie-Tracy, A., Sobolewski, M. D., and Davidson, N. E. (2007) Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines Mol. Cancer Ther. 6, 1013-1021 (Pubitemid 46554571)
155. Wang, R.-H., Zheng, Y., Kim, H.-S., Xu, X., Cao, L., Lahusen, T., Lee, M.-H., Xiao, C., Vassilopoulos, A., Chen, W., Gardner, K., Man, Y.-G., Hung, M-C, Finkel, T., and Deng, C.-X. (2008) Interplay among Brca1, Sirt1, and Survivin during Brac1-associated tumorigenesis Mol. Cell 32, 11-20
156. Bourguignon, L. Y., Xia, W., and Wong, G. (2009) Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells J. Biol. Chem. 284, 2657-2671
157. Cross, S.h., Meehan, R. R., Nan, X., and Bird, A. (1997) A component of the transcriptional repressor MeCP1 shares a motif with DNA methyltransferase and HRX proteins Nat. Genet. 16, 256-259
158. Hendrich, B. and Bird, A. (1998) Identification and characterization of a family of mammalian methyl-CpG binding proteins Mol. Cell. Biol. 18, 6538-6547 (Pubitemid 28500543)
159. Bird, A. P. and Wolffe, A. P. (1999) Methylation-induced repression-belts, braces, and chromatin Cell 99, 451-454 (Pubitemid 129746827)
160. Zhang, Y., Ng, H. H., Erdjument-Bromage, H., Tempst, P., Bird, A., and Reinberg, D. (1999) Analysis of the NuRD subunits reveals a histone deacetylases core complex and a connection with DNA methylation Genes Dev. 13, 1924-1935 (Pubitemid 29407360)
161. Nan, X., Ng, H. H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., and Bird, A (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylases complex Nature 393, 386-389 (Pubitemid 28269714)
162. Chatagnon, A., Bougel, S., Perriaud, L., Benhattar, J., and Dante, R. (2009) Specific association between the methyl-CpG-binding domain protein 2 and the hypermethylated region of the human telomerase reverse transcriptase promoter in cancer cells Carcinogenesis 30, 28-34
163. Bogdanovic, O. and Veenstra, G. J. (2009) DNA methylation and methyl-CpG binding proteins: developmental requirements and function Chromosoma 118, 549-565
164. Muller, H. M., Fiegl, H., Goebel, G., Hubalek, M. M., Widschwendter, A., Muller-Holzner, E., Marth, C., and Widschwendter, M. (2003) MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status Br. J. Cancer 89, 1934-1939 (Pubitemid 37533273)
165. Lin, X. and Nelson, W. G. (2003) Methyl-CpG binding domain protein-2 mediates transcriptional associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells Cancer Res. 63, 498-504 (Pubitemid 36152513)
166. Zhu, Y., Brown, H. N., Zhang, Y., Holford, T. R., and Zheng, T. (2005) Genotypes and haplotypes of the methyl-CpG binding domain 2 modify breast cancer risk dependent upon menopausal status Bresat Cancer Res. 7, R745-R752
167. Ballestar, E., Paz, M. F., Valle, L., Wei, S., Fraga, M. F., Espada, J., Cigudosa, J. C., Huang, T. H., and Esteller, M. (2003) Methyl CpG binding proteins identify novel sites of epigenetic inactivation in human cancer EMBO J. 22, 6335-6345 (Pubitemid 37522590)
168. Lewis, B. P., Burge, C. B., and Bartel, D. P. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are mocroRNA targets Cell 120, 15-17
169. He, L. and Hannon, G. J. (2004) MicroRNAs: small RNAs with a big role in gene regulation Nat. Rev. Genet. 5, 522-531 (Pubitemid 38868508)
170. Weber, b., Stresemann, C., Brueckner, B., and Lyko, F. (2007) Methylation of human MicroRNA genes in normal and neoplastic cells Cell Cycle 6, 1001-1005 (Pubitemid 46708569)
171. Lehmann, U., Hasemeier, B., Christgen, M., Muller, M., Romermann, D., langer, F., and Kreipe, H. (2008) Epigenetic activation of microRNA gene hsa-mir-9-1 in human breast cancer J. Pathol. 214, 17-24
172. Melo, S.a. and Esteller, M. (2011) Dysregulation of microRNAs in cancer: playing with fire FEBS Lett. 585, 2087-2099
173. Iorio, M. V., Ferracin, M., Liu, C. G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., Menard, S., Palazzo, J. P., Rosenberg, A., Musiani, P., Volinia, S., Nenci, I., Calin, G. A., Querzoli, P., Negrini, M., and Croce, C. M. (2005) MicroRNA gene expression deregulation in human breast cancer Cancer Res. 65, 7065-7070 (Pubitemid 41161233)
174. Chuang, J. C. and Jones, P. A. (2007) Epigenetics and microRNAs Pediatr. Res. 61, 24R-29R (Pubitemid 46653064)
175. Si, M. L., Zhu, S., Wu, H., Lu, Z., Wu, F., and Mo, Y. Y. (2007) miR21-mediated tumor growth Oncogene 26, 2799-2803
176. Suzuki, J., Chen, Y. Y., Scott, G. K., Devries, S., Chin, K., Benz, C. C., Waldman, F. M., and Hwang, E. S. (2009) Protein acetylation and histone deacetylases expression associated with malignant breast cancer progression Clin. Cancer Res. 15, 3163-3171
177. Zeisberg, M. and Neilson, E. G. (2009) Biomarkers for epithelial-mesenchymal transitions J. Clin. Invest. 119, 1429-1437
178. Yang, J., Cao, Y., Sun, J., and Zhang, Y. C. (2010) Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells Med Oncol. 27, 1114-1118
179. Hatziapostolou, M. and Iliopoulos, D. (2011) Epigenetic aberrations during oncogenesis Cell. Mol. Life Sci. 68, 1681-1702